Clinical Trial Update: Evaluation of the Practice of the TEP Choline at Patients With Prostate Cancer

View source ↗

Summary

A clinical trial update evaluating how the choline-based PET imaging tracer (TEP Choline) is used in patients with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• TEP Choline PET tracer (choline-based PET radiotracer)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Prostate Cancer | Status: UNKNOWN